via Wikimedia Commons picture of the day feed http://ift.tt/2AufK8I
Thursday, November 30, 2017
November 30, 2017 at 1000AM - 10 - Apple - iPhone X 64GB - Space Gray (Sprint)
November 30, 2017 at 1000AM - 10 - Apple - iPhone X 64GB - Space Gray (Sprint)
Popular on Best Buy at #10 : Apple - iPhone X 64GB - Space Gray (Sprint) http://ift.tt/2i8D54y
November 30, 2017 at 10:06AM
via Instapaper http://ift.tt/2i8D54y
Popular on Best Buy at #10 : Apple - iPhone X 64GB - Space Gray (Sprint) http://ift.tt/2i8D54y
November 30, 2017 at 10:06AM
via Instapaper http://ift.tt/2i8D54y
November 30, 2017 at 1000AM - 9 - Apple - iPhone X 256GB - Space Gray (Verizon)
November 30, 2017 at 1000AM - 9 - Apple - iPhone X 256GB - Space Gray (Verizon)
Popular on Best Buy at #9 : Apple - iPhone X 256GB - Space Gray (Verizon) http://ift.tt/2iCVJ8J
November 30, 2017 at 10:05AM
via Instapaper http://ift.tt/2iCVJ8J
Popular on Best Buy at #9 : Apple - iPhone X 256GB - Space Gray (Verizon) http://ift.tt/2iCVJ8J
November 30, 2017 at 10:05AM
via Instapaper http://ift.tt/2iCVJ8J
Articles from Slashdot
Articles from Slashdot
Microsoft's Edge Browser Now Generally Available For iOS, Android: http://ift.tt/2Au0mJL
November 30, 2017 at 09:56AM
via Instapaper http://ift.tt/2Au0mJL
Microsoft's Edge Browser Now Generally Available For iOS, Android: http://ift.tt/2Au0mJL
November 30, 2017 at 09:56AM
via Instapaper http://ift.tt/2Au0mJL
Articles from Slashdot
Articles from Slashdot
Google Launches App That Can Help You Track and Conserve Mobile Data: http://ift.tt/2jA5jpJ
November 30, 2017 at 09:19AM
via Instapaper http://ift.tt/2Aq6bb1
Google Launches App That Can Help You Track and Conserve Mobile Data: http://ift.tt/2jA5jpJ
November 30, 2017 at 09:19AM
via Instapaper http://ift.tt/2Aq6bb1
New top story on Hacker News: It Looks Like Nobel Economics Laureates Don't Like Bitcoin
It Looks Like Nobel Economics Laureates Don't Like Bitcoin
4 by champagnepapi | 0 comments on Hacker News.
4 by champagnepapi | 0 comments on Hacker News.
Articles from Slashdot
Articles from Slashdot
New Study Finds That Most Redditors Don't Actually Read the Articles They Vote On: http://ift.tt/2BBxsF1
November 30, 2017 at 08:26AM
via Instapaper http://ift.tt/2zB3S19
New Study Finds That Most Redditors Don't Actually Read the Articles They Vote On: http://ift.tt/2BBxsF1
November 30, 2017 at 08:26AM
via Instapaper http://ift.tt/2zB3S19
New top story on Hacker News: Judge Tells Uber Lawyer: ‘It Looks Like You Covered This Up’
Judge Tells Uber Lawyer: ‘It Looks Like You Covered This Up’
4 by Cbasedlifeform | 0 comments on Hacker News.
4 by Cbasedlifeform | 0 comments on Hacker News.
On Sale Treasures of Montezuma 3 by Treasures of Montezuma 3
On Sale Treasures of Montezuma 3 by Treasures of Montezuma 3
Treasures of Montezuma 3 by Treasures of Montezuma 3 dropped in price from $1.99 to $0.99. Download via AppZapp http://ift.tt/1lbTMKu
November 30, 2017 at 08:03AM
via Instapaper http://ift.tt/1lbTMKu
Treasures of Montezuma 3 by Treasures of Montezuma 3 dropped in price from $1.99 to $0.99. Download via AppZapp http://ift.tt/1lbTMKu
November 30, 2017 at 08:03AM
via Instapaper http://ift.tt/1lbTMKu
On Sale The Treasures Of Montezuma 4 by Alawar Entertainment, Inc.
On Sale The Treasures Of Montezuma 4 by Alawar Entertainment, Inc.
The Treasures Of Montezuma 4 by Alawar Entertainment, Inc. dropped in price from $1.99 to $0.99. Download via AppZapp http://ift.tt/1LP2SXJ
November 30, 2017 at 08:03AM
via Instapaper http://ift.tt/1LP2SXJ
The Treasures Of Montezuma 4 by Alawar Entertainment, Inc. dropped in price from $1.99 to $0.99. Download via AppZapp http://ift.tt/1LP2SXJ
November 30, 2017 at 08:03AM
via Instapaper http://ift.tt/1LP2SXJ
Articles from Slashdot
Articles from Slashdot
American Airlines Accidentally Let Too Many Pilots Take Off The Holidays: http://ift.tt/2i5xAUQ
November 30, 2017 at 07:45AM
via Instapaper http://ift.tt/2i3bp1l
American Airlines Accidentally Let Too Many Pilots Take Off The Holidays: http://ift.tt/2i5xAUQ
November 30, 2017 at 07:45AM
via Instapaper http://ift.tt/2i3bp1l
New cancer clinical trial: Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
Published on: November 30, 2017 at 10:00AM
Condition: Prostate Cancer
Interventions: Drug: Docetaxel; Drug: Degarelix; Drug: Bicalutamide
Sponsors: University of Wisconsin, Madison; United States Department of Defense; National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2i6pFX7
Condition: Prostate Cancer
Interventions: Drug: Docetaxel; Drug: Degarelix; Drug: Bicalutamide
Sponsors: University of Wisconsin, Madison; United States Department of Defense; National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2i6pFX7
New cancer clinical trial: Engineering Gut Microbiome to Target Breast Cancer
Published on: November 30, 2017 at 10:00AM
Condition: Breast Cancer
Intervention: Dietary Supplement: Probiotic
Sponsor: Mayo Clinic
Recruiting
http://ift.tt/2jxJhDY
Condition: Breast Cancer
Intervention: Dietary Supplement: Probiotic
Sponsor: Mayo Clinic
Recruiting
http://ift.tt/2jxJhDY
New cancer clinical trial: Radiotherapy vs Neck Dissection for Clinical T1/2N0 Supraglottic Cancer
Published on: November 30, 2017 at 10:00AM
Condition: Supraglottic Cancer
Interventions: Radiation: Radiatherapy; Procedure: Selective neck dissection
Sponsors: Tianjin Medical University Cancer Institute and Hospital; Tianjin Medical University General Hospital; Tianjin Medical University Second Hospital
Not yet recruiting
http://ift.tt/2zQqX3U
Condition: Supraglottic Cancer
Interventions: Radiation: Radiatherapy; Procedure: Selective neck dissection
Sponsors: Tianjin Medical University Cancer Institute and Hospital; Tianjin Medical University General Hospital; Tianjin Medical University Second Hospital
Not yet recruiting
http://ift.tt/2zQqX3U
New cancer clinical trial: Cancer Patients Treated With Immunotherapy in Intensive Care Unit
Published on: November 30, 2017 at 10:00AM
Conditions: Cancer; Critical Illness; Immunotherapy
Intervention:
Sponsor: University Hospital, Grenoble
Not yet recruiting
http://ift.tt/2AIMefT
Conditions: Cancer; Critical Illness; Immunotherapy
Intervention:
Sponsor: University Hospital, Grenoble
Not yet recruiting
http://ift.tt/2AIMefT
New cancer clinical trial: Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer
Published on: November 30, 2017 at 10:00AM
Condition: Triple Negative Breast Cancer
Interventions: Drug: Zoledronate; Drug: Atorvastatin 80mg; Drug: Standard neoadjuvant cht
Sponsors: Mario Negri Institute for Pharmacological Research; Associazione Italiana per la Ricerca sul Cancro
Not yet recruiting
http://ift.tt/2zPs6J3
Condition: Triple Negative Breast Cancer
Interventions: Drug: Zoledronate; Drug: Atorvastatin 80mg; Drug: Standard neoadjuvant cht
Sponsors: Mario Negri Institute for Pharmacological Research; Associazione Italiana per la Ricerca sul Cancro
Not yet recruiting
http://ift.tt/2zPs6J3
New cancer clinical trial: LATENT: Lytic Activation To Enhance Neoantigen-directed Therapy A Combination of Anti-viral and Immune Therapy for the Treatment of Cancers Associated With Chronic Viral Infections
Published on: November 30, 2017 at 10:00AM
Condition: Cancer That is Associated With a Chronic Viral Infection
Interventions: Drug: Valproic Acid; Biological: Avelumab
Sponsors: AHS Cancer Control Alberta; EMD Serono / Merck
Not yet recruiting
http://ift.tt/2AHEWsQ
Condition: Cancer That is Associated With a Chronic Viral Infection
Interventions: Drug: Valproic Acid; Biological: Avelumab
Sponsors: AHS Cancer Control Alberta; EMD Serono / Merck
Not yet recruiting
http://ift.tt/2AHEWsQ
New cancer clinical trial: the Role of Two Different Metronomic Chemotherapy Regimens in Locally Advanced or Metastatic Triple Negative Breast Cancer Patients (TNBC) as Maintenance Therapy After First Line Treatment
Published on: November 30, 2017 at 10:00AM
Condition: Triple Negative Breast Cancer
Interventions: Drug: Vinorelbine Tartrate; Drug: Capecitabine 500 MG
Sponsor: Mario Negri Institute for Pharmacological Research
Recruiting
http://ift.tt/2zRrSBh
Condition: Triple Negative Breast Cancer
Interventions: Drug: Vinorelbine Tartrate; Drug: Capecitabine 500 MG
Sponsor: Mario Negri Institute for Pharmacological Research
Recruiting
http://ift.tt/2zRrSBh
New cancer clinical trial: Molecular Evaluation in Metastatic Breast Cancer
Published on: November 30, 2017 at 10:00AM
Conditions: Metastatic Breast Cancer; Molecular Imaging
Intervention: Diagnostic Test: FDG-PET/CT
Sponsor: Odense University Hospital
Recruiting
http://ift.tt/2AJvDIO
Conditions: Metastatic Breast Cancer; Molecular Imaging
Intervention: Diagnostic Test: FDG-PET/CT
Sponsor: Odense University Hospital
Recruiting
http://ift.tt/2AJvDIO
New cancer clinical trial: Safety and Efficacy of Post-operative Denosumab Strategy for Giant Cell Tumor of Bone Treatment in China
Published on: November 30, 2017 at 10:00AM
Condition: Giant Cell Tumor of Bone
Intervention: Drug: Denosumab
Sponsor: Peking University People's Hospital
Not yet recruiting
http://ift.tt/2zRKpxk
Condition: Giant Cell Tumor of Bone
Intervention: Drug: Denosumab
Sponsor: Peking University People's Hospital
Not yet recruiting
http://ift.tt/2zRKpxk
New cancer clinical trial: Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage?
Published on: November 30, 2017 at 10:00AM
Conditions: Pancreatic Cancer; Biliary Stasis
Intervention: Device: Tannenbaum Fr 10 stent or WallFlex stent
Sponsor: Helsinki University Central Hospital
Recruiting
http://ift.tt/2AKLI1b
Conditions: Pancreatic Cancer; Biliary Stasis
Intervention: Device: Tannenbaum Fr 10 stent or WallFlex stent
Sponsor: Helsinki University Central Hospital
Recruiting
http://ift.tt/2AKLI1b
New cancer clinical trial: Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia
Published on: November 30, 2017 at 10:00AM
Condition: Ataxia Telangiectasia
Interventions: Diagnostic Test: bioelectrical impedance analysis; Diagnostic Test: blood draw; Diagnostic Test: transient elastography (FibroScan); Diagnostic Test: ataxia score; Diagnostic Test: Five-Times-Sit-to-Stand Test
Sponsor: Johann Wolfgang Goethe University Hospital
Recruiting
http://ift.tt/2zRgfub
Condition: Ataxia Telangiectasia
Interventions: Diagnostic Test: bioelectrical impedance analysis; Diagnostic Test: blood draw; Diagnostic Test: transient elastography (FibroScan); Diagnostic Test: ataxia score; Diagnostic Test: Five-Times-Sit-to-Stand Test
Sponsor: Johann Wolfgang Goethe University Hospital
Recruiting
http://ift.tt/2zRgfub
Curved displays – practical or used just for looks?
Curved displays – practical or used just for looks?
http://ift.tt/2i4xi0A
November 30, 2017 at 07:16AM
via Instapaper http://ift.tt/2i4xi0A
http://ift.tt/2i4xi0A
November 30, 2017 at 07:16AM
via Instapaper http://ift.tt/2i4xi0A
Coinbase ordered to report 14,355 users to the IRS
Coinbase ordered to report 14,355 users to the IRS
http://ift.tt/2irhUPH
November 30, 2017 at 07:14AM
via Instapaper http://ift.tt/2BmKwgw
http://ift.tt/2irhUPH
November 30, 2017 at 07:14AM
via Instapaper http://ift.tt/2BmKwgw
The USAF Is Rebuilding World War II-Era 40mm Shells for its AC-130U Gunships
The USAF Is Rebuilding World War II-Era 40mm Shells for its AC-130U Gunships
http://ift.tt/2zRhQ30
November 30, 2017 at 07:14AM
via Instapaper http://ift.tt/2jwBjLi
http://ift.tt/2zRhQ30
November 30, 2017 at 07:14AM
via Instapaper http://ift.tt/2jwBjLi
Articles from Slashdot
Articles from Slashdot
Google Faces Lawsuit For Gathering Personal Data From Millions of iPhone Users: http://ift.tt/2j4C7rm
November 30, 2017 at 07:05AM
via Instapaper http://ift.tt/2i341D9
Google Faces Lawsuit For Gathering Personal Data From Millions of iPhone Users: http://ift.tt/2j4C7rm
November 30, 2017 at 07:05AM
via Instapaper http://ift.tt/2i341D9
Articles from Slashdot
Articles from Slashdot
Nasdaq Plans To Offer Bitcoin Futures In Early 2018: http://ift.tt/2i34Uvv
November 30, 2017 at 06:35AM
via Instapaper http://ift.tt/2isSKjs
Nasdaq Plans To Offer Bitcoin Futures In Early 2018: http://ift.tt/2i34Uvv
November 30, 2017 at 06:35AM
via Instapaper http://ift.tt/2isSKjs
Personal Income and Outlays, October 2017
Personal Income and Outlays, October 2017
Personal income increased $65.1 billion (0.4 percent) in October according to estimates released today by the Bureau of Economic Analysis. Disposable personal income (DPI) increased $66.1 billion (0.5 percent) and personal consumption expenditures (PCE) increased $34.4 billion (0.3 percent). Full Text
Published November 30, 2017 at 06:30AM
Read more at bea.gov
Personal income increased $65.1 billion (0.4 percent) in October according to estimates released today by the Bureau of Economic Analysis. Disposable personal income (DPI) increased $66.1 billion (0.5 percent) and personal consumption expenditures (PCE) increased $34.4 billion (0.3 percent). Full Text
Published November 30, 2017 at 06:30AM
Read more at bea.gov
Top videos on Twitch
Top videos on Twitch
New top video of the week on Twitch: MSF Vapora Dark | Leveling my Teem only smurf http://ift.tt/2ircEvm
November 30, 2017 at 06:33AM
via Instapaper http://ift.tt/2ircEvm
New top video of the week on Twitch: MSF Vapora Dark | Leveling my Teem only smurf http://ift.tt/2ircEvm
November 30, 2017 at 06:33AM
via Instapaper http://ift.tt/2ircEvm
New top story on Hacker News: SmartAsset (YC S12) Is Hiring Back End Developers in NYC
SmartAsset (YC S12) Is Hiring Back End Developers in NYC
1 by philipcamilleri | 0 comments on Hacker News.
1 by philipcamilleri | 0 comments on Hacker News.
Articles from Slashdot
Articles from Slashdot
Study Finds Dogs Are Brainier Than Cats: http://ift.tt/2AguZ4w
November 30, 2017 at 03:05AM
via Instapaper http://ift.tt/2ApBiU0
Study Finds Dogs Are Brainier Than Cats: http://ift.tt/2AguZ4w
November 30, 2017 at 03:05AM
via Instapaper http://ift.tt/2ApBiU0
IoT Podcast
IoT Podcast
IoT Podcast Episode 140: How IoT will change war: http://ift.tt/2i131zv
November 30, 2017 at 03:05AM
via Instapaper http://ift.tt/2i131zv
IoT Podcast Episode 140: How IoT will change war: http://ift.tt/2i131zv
November 30, 2017 at 03:05AM
via Instapaper http://ift.tt/2i131zv
Wednesday, November 29, 2017
Wikimedia Commons picture of the day for November 30
via Wikimedia Commons picture of the day feed http://ift.tt/2AoXSfi
New top story on Hacker News: Ask HN: How do I get $2.2M dollars?
Ask HN: How do I get $2.2M dollars?
3 by gallerdude | 1 comments on Hacker News.
I've decided that the optimal path I want in life is $2.2 million dollars, and then to live the rest of my life off of the interest generated from an index fund (approx $80K/year after tax). Right now I'm in college studying Computer Science, and in my free time I write (I'm not any good at either yet, but now's the time to get good, so I'm not worried). I've thought about a start-up, but the risk and reward are both too high. A successful startup is around the $10 million to $1 billion, depending on what you create. This is way over my goal. I'm sure the risk is proportional to the potential money earned, so it'd be inefficient to overshoot my target.
3 by gallerdude | 1 comments on Hacker News.
I've decided that the optimal path I want in life is $2.2 million dollars, and then to live the rest of my life off of the interest generated from an index fund (approx $80K/year after tax). Right now I'm in college studying Computer Science, and in my free time I write (I'm not any good at either yet, but now's the time to get good, so I'm not worried). I've thought about a start-up, but the risk and reward are both too high. A successful startup is around the $10 million to $1 billion, depending on what you create. This is way over my goal. I'm sure the risk is proportional to the potential money earned, so it'd be inefficient to overshoot my target.
New grant opportunity on Grants.gov: Evaluation of Human Resources for Health in the Republic of Rwanda under the President's Emergency Plan for AIDS Relief (PEPFAR)
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: Native American Affairs: Technical Assistance to Tribes for Fiscal Year 2018
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: ROSES 2017: Magnetospheric Multiscale Guest Investigators
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: ROSES 2017: Habitable Worlds
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: Energy Efficiency Research and Development for Fluid-Power Systems In Off-Road Vehicles
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: 2018 Pacific Northwest Bay-Watershed Education and Training
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: PPHF 2018; Immunization Information Systems Sentinel Site Project Financed in Part by 2018 Prevention and Public Health Funds
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: 2018 SBIR/STTR Phase I Release 1
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: FOA: State Energy Program 2017 Competitive Awards
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: Research Centers for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (UM1)
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: Coordinating Center for Improving Management of Symptoms Across Cancer Treatments (IMPACT) (U24)
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: DoD Lupus, Impact Award
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: Youth Training and Work Experience through Habitat Restoration at Peter Strauss Ranch
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: FY18 ENVIRONMENTAL WORKFORCE DEVELOPMENT AND JOB TRAINING (EWDJT) GRANTS
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
New grant opportunity on Grants.gov: Small Community Air Service Development Program
|
Published at: November 29, 2017 at 08:15AM
View on Grants.gov
Popular on Best Buy : WowWee - Fingerlings Baby Monkeys Mia
New cancer clinical trial: Mix Vaccine for Metastatic Colorectal Cancer
Published on: November 29, 2017 at 10:00AM
Conditions: Metastatic Colorectal Cancer; Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AjuO6w
Conditions: Metastatic Colorectal Cancer; Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AjuO6w
New cancer clinical trial: Mix Vaccine for Metastatic Kidney Cancer
Published on: November 29, 2017 at 10:00AM
Conditions: Metastasis From Malignant Tumor of Kidney (Disorder); Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AcZpVv
Conditions: Metastasis From Malignant Tumor of Kidney (Disorder); Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AcZpVv
New cancer clinical trial: Intervention of CAR-T Against Lung Cancer
Published on: November 29, 2017 at 10:00AM
Condition: Lung Cancer
Intervention: Biological: Lung cancer-specific CAR-T cells
Sponsor: Shenzhen Geno-Immune Medical Institute
Not yet recruiting
http://ift.tt/2j1rbLi
Condition: Lung Cancer
Intervention: Biological: Lung cancer-specific CAR-T cells
Sponsor: Shenzhen Geno-Immune Medical Institute
Not yet recruiting
http://ift.tt/2j1rbLi
New cancer clinical trial: Intervention of CAR-T Against Cervical Cancer
Published on: November 29, 2017 at 10:00AM
Condition: Cervical Cancer
Intervention: Biological: Cervical cancer-specific CAR-T cells
Sponsor: Shenzhen Geno-Immune Medical Institute
Recruiting
http://ift.tt/2AkAxJe
Condition: Cervical Cancer
Intervention: Biological: Cervical cancer-specific CAR-T cells
Sponsor: Shenzhen Geno-Immune Medical Institute
Recruiting
http://ift.tt/2AkAxJe
New cancer clinical trial: Circulating Tumor DNA After Neoadjuvant Chemotherapy
Published on: November 29, 2017 at 10:00AM
Condition: Breast Cancer
Intervention: Other: Follow-up after neoadjuvant chemotherapy
Sponsors: Institut Bergonié; Fondation Bergonié
Recruiting
http://ift.tt/2AffxG7
Condition: Breast Cancer
Intervention: Other: Follow-up after neoadjuvant chemotherapy
Sponsors: Institut Bergonié; Fondation Bergonié
Recruiting
http://ift.tt/2AffxG7
New cancer clinical trial: A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
Published on: November 29, 2017 at 10:00AM
Condition: Metastatic Colorectal Cancer
Interventions: Biological: CPGJ602; Biological: Cetuximab
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Recruiting
http://ift.tt/2AiIVsJ
Condition: Metastatic Colorectal Cancer
Interventions: Biological: CPGJ602; Biological: Cetuximab
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Recruiting
http://ift.tt/2AiIVsJ
New cancer clinical trial: Change in Symptom Clusters in HNC Patients
Published on: November 29, 2017 at 10:00AM
Condition: Neoplasms, Head and Neck
Intervention: Other: complete questionnaire
Sponsor: Taipei Medical University
Completed
http://ift.tt/2Ah88ps
Condition: Neoplasms, Head and Neck
Intervention: Other: complete questionnaire
Sponsor: Taipei Medical University
Completed
http://ift.tt/2Ah88ps
New cancer clinical trial: Mix Vaccine for Metastatic Sarcoma
Published on: November 29, 2017 at 10:00AM
Conditions: Metastatic Sarcoma; Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AitKQn
Conditions: Metastatic Sarcoma; Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AitKQn
New cancer clinical trial: Safety and Efficacy of Durvalumab Combined to Neoadjuvant Chemotherapy in Localized Luminal B HER2(-) and Triple Negative Breast Cancer.
Published on: November 29, 2017 at 10:00AM
Conditions: Breast Cancer; Triple Negative Breast Cancer; Luminal B
Interventions: Drug: Paclitaxel; Drug: Epirubicin; Drug: Cyclophosphamide; Drug: Durvalumab
Sponsors: Grand Hôpital de Charleroi; Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Recruiting
http://ift.tt/2Ah85dg
Conditions: Breast Cancer; Triple Negative Breast Cancer; Luminal B
Interventions: Drug: Paclitaxel; Drug: Epirubicin; Drug: Cyclophosphamide; Drug: Durvalumab
Sponsors: Grand Hôpital de Charleroi; Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Recruiting
http://ift.tt/2Ah85dg
New cancer clinical trial: "CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer (mCRPC) Progressed During or After a Previous Docetaxel-based Chemotherapy
Published on: November 29, 2017 at 10:00AM
Conditions: Prostate Cancer; Castration-resistant Prostate Cancer
Intervention: Drug: Cabazitaxel
Sponsor: Consorzio Oncotech
Not yet recruiting
http://ift.tt/2AkPuLw
Conditions: Prostate Cancer; Castration-resistant Prostate Cancer
Intervention: Drug: Cabazitaxel
Sponsor: Consorzio Oncotech
Not yet recruiting
http://ift.tt/2AkPuLw
New cancer clinical trial: Spectrum Analysis in Ex-vivo Human Lungs
Published on: November 29, 2017 at 10:00AM
Condition: Lung Cancer
Intervention: Device: Spectrum Analysis
Sponsor: University Health Network, Toronto
Recruiting
http://ift.tt/2Ah7ZSW
Condition: Lung Cancer
Intervention: Device: Spectrum Analysis
Sponsor: University Health Network, Toronto
Recruiting
http://ift.tt/2Ah7ZSW
New cancer clinical trial: Evaluation of ABEMACICLIB Monotherapy in Patients With Locally Advanced/Metastatic Head and Neck Cancer After Failure of Platinum and Cetuximab or Anti-EGFR-based Therapy and Harboring an Homozygous Deletion of CDKN2A, and/or an Amplification of CCND1 and/or of CDK6
Published on: November 29, 2017 at 10:00AM
Conditions: Head and Neck Cancer; Advanced Cancer; Metastatic Cancer
Intervention: Drug: Abemaciclib
Sponsor: Centre Leon Berard
Not yet recruiting
http://ift.tt/2AiIUVH
Conditions: Head and Neck Cancer; Advanced Cancer; Metastatic Cancer
Intervention: Drug: Abemaciclib
Sponsor: Centre Leon Berard
Not yet recruiting
http://ift.tt/2AiIUVH
New cancer clinical trial: Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
Published on: November 29, 2017 at 10:00AM
Condition: Melanoma
Intervention: Other: F-FDG PET/CT
Sponsors: University of Wisconsin, Madison; National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2Ah7XKO
Condition: Melanoma
Intervention: Other: F-FDG PET/CT
Sponsors: University of Wisconsin, Madison; National Cancer Institute (NCI)
Not yet recruiting
http://ift.tt/2Ah7XKO
New cancer clinical trial: Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate
Published on: November 29, 2017 at 10:00AM
Conditions: Prostate Cancer; Castration-resistant Prostate Cancer; Drug
Interventions: Drug: Abiraterone Acetate; Drug: Docetaxel
Sponsor: West China Hospital
Not yet recruiting
http://ift.tt/2AipvnT
Conditions: Prostate Cancer; Castration-resistant Prostate Cancer; Drug
Interventions: Drug: Abiraterone Acetate; Drug: Docetaxel
Sponsor: West China Hospital
Not yet recruiting
http://ift.tt/2AipvnT
New cancer clinical trial: Apatinib Plus Radiotherapy for Patients With Brain Metastases From Non-small-cell Lung Cancer
Published on: November 29, 2017 at 10:00AM
Condition: Brain Metastases
Intervention: Combination Product: Apatinib plus radiotherapy
Sponsor: Shanxi Province Cancer Hospital
Not yet recruiting
http://ift.tt/2AdooYR
Condition: Brain Metastases
Intervention: Combination Product: Apatinib plus radiotherapy
Sponsor: Shanxi Province Cancer Hospital
Not yet recruiting
http://ift.tt/2AdooYR
New cancer clinical trial: Mix Vaccine for Metastatic Colorectal Cancer
Published on: November 29, 2017 at 10:00AM
Conditions: Metastatic Colorectal Cancer; Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AjuO6w
Conditions: Metastatic Colorectal Cancer; Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AjuO6w
New cancer clinical trial: Mix Vaccine for Metastatic Kidney Cancer
Published on: November 29, 2017 at 10:00AM
Conditions: Metastasis From Malignant Tumor of Kidney (Disorder); Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AcZpVv
Conditions: Metastasis From Malignant Tumor of Kidney (Disorder); Reaction - Mixed Vaccine
Intervention: Biological: Mix vaccine
Sponsors: Fuda Cancer Hospital, Guangzhou; Biomedical Translational Research Institute of Jinan University
Recruiting
http://ift.tt/2AcZpVv
New cancer clinical trial: Intervention of CAR-T Against Lung Cancer
Published on: November 29, 2017 at 10:00AM
Condition: Lung Cancer
Intervention: Biological: Lung cancer-specific CAR-T cells
Sponsor: Shenzhen Geno-Immune Medical Institute
Not yet recruiting
http://ift.tt/2j1rbLi
Condition: Lung Cancer
Intervention: Biological: Lung cancer-specific CAR-T cells
Sponsor: Shenzhen Geno-Immune Medical Institute
Not yet recruiting
http://ift.tt/2j1rbLi
Subscribe to:
Posts (Atom)